Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System

RIVER EDGE, N.J., Nov. 10, 2011 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH) announced that it has received the initial review by the Food and Drug Administration ("FDA") of the 510(k) application for marketing clearance of the company's hemodiafiltration system. On August 11, 2011 Nephros submitted a new 510(k) application to market its hemodiafiltration (HDF) system for end-stage renal disease.  On November 8, 2011 Nephros received the initial FDA review of its new 510(k) applicatio...continued NEPH

URL: http://www.investorpoint.com/news/OTCBULLB/46033935/